CORCEPT THERAPEUTICS INC Lessee, Operating Lease, Liability, to be Paid, Year One
CORCEPT THERAPEUTICS INC (CORT) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.70 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-07-29
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.70M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.70M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.55M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.55M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $2.70M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $1.55M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.55M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.55M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $1.55M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $1.38M 10-K · filed 2025-02-26 |
| 2024-09-30 | $1.38M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $1.38M 10-Q · filed 2024-07-29 |
| 2023-12-31 | $155.00K 10-K · filed 2024-02-15 |
| 2023-09-30 | $155.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $155.00K 10-Q · filed 2023-08-02 |
| 2022-12-31 | $1.16M 10-K · filed 2023-02-28 |
| 2022-09-30 | $1.16M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.16M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.16M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $530.00K 10-K · filed 2022-02-15 |
| 2020-12-31 | $2.11M 10-K · filed 2021-02-23 |
| 2020-09-30 | $2.11M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $2.11M 10-Q · filed 2020-08-04 |
| 2019-12-31 | $2.00M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |